MDRX · Veradigm Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $151.92M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | $68.49M |
| Gross Profit | - | - | - | - | - | - | - | - | - | $83.44M |
| R&D | - | - | - | - | - | - | - | - | - | $23.68M |
| SG&A | - | - | - | - | - | - | - | - | - | $32.52M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - | - | $25.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | $1.25M |
| Income Tax | - | - | - | - | - | - | - | - | - | $13.87M |
| Net Income | - | - | - | - | - | - | - | - | - | $14.53M |
| EPS - Basic | - | - | - | - | - | - | - | - | - | $0.13 |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | $0.12 |
Balance Sheet
| Line item | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $294.25M | $302.27M | $330.72M | $343.50M | $446.60M | $455.74M | $471.20M | $453.94M | $446.59M | $492.60M |
| Accounts Receivable | $107.63M | $114.22M | $120.97M | $110.92M | $111.16M | $118.12M | $116.56M | $114.90M | $119.15M | $169.03M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $30.95M | $43.05M | $49.66M | $58.68M | $21.28M | $36.49M | $33.58M | $20.75M | $30.84M | $12.61M |
| Current Assets | $545.65M | $556.89M | $586.70M | $606.76M | $699.18M | $716.00M | $711.68M | $695.59M | $679.65M | $810.77M |
| Total Assets | $1.35B | $1.46B | $1.49B | $1.52B | $1.57B | $1.58B | $1.56B | $1.54B | $1.50B | $1.69B |
| Current Liabilities | $421.87M | $421.03M | $427.25M | $502.07M | $445.98M | $453.88M | $452.17M | $459.13M | $230.31M | $253.09M |
| Long-term Debt | $72.23M | $72.23M | $72.23M | $0 | $0 | - | - | - | $200.40M | $200.33M |
| Total Liabilities | $548.30M | $550.00M | $561.54M | $565.65M | $498.44M | $511.44M | $510.65M | $518.17M | $487.22M | $513.64M |
| Stockholders' Equity | $804.02M | $911.33M | $929.20M | $949.97M | $1.07B | $1.07B | $1.05B | $1.02B | $1.02B | $1.18B |
| Retained Earnings | $403.44M | $517.05M | $541.44M | $566.11M | $694.99M | $689.00M | $672.53M | $647.47M | $645.81M | $753.39M |
Cash Flow
| Line item | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | $7.98M | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | 54.9% |
| Operating margin | - | - | - | - | - | - | - | - | - | 16.5% |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | 9.6% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | 15.6% |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | 21.4% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | 48.8% |
| Return on assets | - | - | - | - | - | - | - | - | - | 0.9% |
| Return on equity | - | - | - | - | - | - | - | - | - | 1.2% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | 0.9% |
| Liquidity | ||||||||||
| Current ratio | 1.29 | 1.32 | 1.37 | 1.21 | 1.57 | 1.58 | 1.57 | 1.52 | 2.95 | 3.20 |
| Quick ratio | 1.29 | 1.32 | 1.37 | 1.21 | 1.57 | 1.58 | 1.57 | 1.52 | 2.95 | 3.20 |
| Cash ratio | 0.70 | 0.72 | 0.77 | 0.68 | 1.00 | 1.00 | 1.04 | 0.99 | 1.94 | 1.95 |
| Leverage | ||||||||||
| Debt / Equity | 0.09 | 0.08 | 0.08 | 0.00 | 0.00 | - | - | - | 0.20 | 0.17 |
| Debt / Assets | 0.05 | 0.05 | 0.05 | 0.00 | 0.00 | - | - | - | 0.13 | 0.12 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | 20.1x |
| Equity multiplier | 1.68 | 1.60 | 1.60 | 1.60 | 1.46 | 1.48 | 1.49 | 1.51 | 1.48 | 1.44 |
| Liabilities / Assets | 0.41 | 0.38 | 0.38 | 0.37 | 0.32 | 0.32 | 0.33 | 0.34 | 0.32 | 0.30 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | 0.09 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | 406d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | 67d |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | 126.9x |
| P / B | - | - | - | - | - | - | - | - | - | 1.7x |
| P / S | - | - | - | - | - | - | - | - | - | 12.9x |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | -58.9% |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | -30.1% |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | -19.5% |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | -43.9% |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | 106.6% |
| Net income growth (YoY) | - | - | - | - | - | - | - | - | - | -10.2% |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | 0.0% |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -25.2% | -14.5% | -11.3% | -7.1% | 5.6% | -9.5% | -12.4% | -24.4% | -27.7% | -17.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-12-31.
Business segments
$594.41M totalProvider$473.06M · 79.6%
Payer$67.31M · 11.3%
Life Science$54.04M · 9.1%
Geographic
$594.41M totalUS$593.71M · 99.9%
Non Us$699.0K · 0.1%
Peer comparison
Same SIC group: Services-Computer Integrated Systems Design
Comparing Veradigm Inc. against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Oct 13, 2008 | $5.2300 |